Filing Details

Accession Number:
0001078782-13-002392
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-04 12:52:34
Reporting Period:
2013-11-25
Filing Date:
2013-12-04
Accepted Time:
2013-12-04 12:52:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579377 Archibald Guy Innes 1 Scotts Road, #24-05 Shaw Centre
Singapore U0 228208
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-25 132,246 $271,102.70 1,064,341 No 4 P Direct
Common Stock Acquisiton 2013-12-02 4,878 $9,999.90 1,069,219 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 5 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock WARRANT Acquisiton 2013-11-25 132,246 $271,102.70 132,246 $2.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
337,067 2013-11-25 2018-11-25 No 4 P Direct
Footnotes
  1. A total of 132,246 Units (1 Unit = 1 common share + 1 warrant to purchase 1 common share) were acquired on November 25, 2013, of which 121,952 Units were purchased at a cost basis of $2.05 per Unit and 10,294 Units were acquired pursuant to the settlement of an existing debt between the Company and Guy Archibald Innes valued at $21,102.70.
  2. The 4,878 shares were purchased at a cost basis of $2.05 per share.